| Tag | Content |
|---|
EnhancerAtlas ID | HS122-01255 |
Organism | Homo sapiens |
Tissue/cell | LoVo |
Coordinate | chr1:212870990-212873010 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Mafb | MA0117.2 | chr1:212871030-212871042 | AGTCAGCAAATT | - | 6.22 | | ZIC3 | MA0697.1 | chr1:212872952-212872967 | CGCCCCCCGCGGCGC | + | 6.36 | | ZIC4 | MA0751.1 | chr1:212872952-212872967 | CGCCCCCCGCGGCGC | + | 6.02 | | ZNF740 | MA0753.2 | chr1:212872595-212872608 | GCACCCCCCCCAC | + | 6.74 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_19736 | chr1:212870243-212879706 | CD4p_CD25-_Il17p_PMAstim_Th17 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | TACTCATTTG AACAATGCTT GGCTGACATT TTGTTTCAGA AGTCAGCAAA TTTTTTATGT 60
GTCTTGAAAG CTGTTAGCTA TATGTAAGAT TTAACCAAAT TCAGTCAAAT CCCTCAATAG 120
TGATCATGAA ACAGGCAGGC GGAAAAATGC ACTGACCATG GTAAAAACAC TTCAATCAGC 180
TATAGAAAAC ATGAAAAAGG AGAGCAGTAT TTGCTTTCTA GAACCCCATG AGAAGACACC 240
ACCAAGCGGG AAAAATACCA CACTTACAGA GTTTAAGAGC CAAGAGGTAC AAACAAGGAA 300
AACTACTCAG TTATTAATAT TCACGGAATG CAAATATTAA TAACACAAAA AAGGATATTT 360
TCAGTTATCA TTTGATCTCA TCTTGTATTC CACATAAGAC ACACATCTTC CCAAGTTACT 420
GCAGGTAAGA AGTTTCAGAT ATGCAAGAAT ATAAAGGCAT AAAAAGGAGA GGAATAAATA 480
ACATACATAG CAAATAGAAG CTTAAGGGAA CAAAGTATGA TAATACAGTC TTCTAGAGAG 540
GCAAAGAAGT CTTGATAAAC AAAACCAGAA CATTACAGGG GAACATGTGG TTAGAAGACA 600
GCTCTTTAGC TTTAGAATCA CACAGATCCT AGTTTTGTCT CTTAGTGTCA ACATGGTCTT 660
GTGTAAATGG TTTAAATTCT CTAAATTTTC AGTTTTCTCA TTTATTGTAA GCATAATTCA 720
TTCATTCTTT CAATATGTAT TAACTGAGCA CCTACCATGT GCCAGACACT GTTCTAGACA 780
CTGGGGATAC AAGCCCTAAA CAAAGGGTCA GTGAACTCTG CAGACTTGGT GCTAACAGCC 840
TAATGCTTAG GATTGGGATG CGATGAAATG AGATTTTGTC CTAAAGCTCC CAGCATACAG 900
TATGCCCTCA AGAAGTTACC TGCCTTTGTT GAAGTTGCTA CTTTAAAAAA AAATGTATTC 960
TGCATAGTGC TTCTCATGCC TCTTTGCTCT CTGTAATCAA AAAGTCACTA GCACAAGAAA 1020
GCAGCCTGCA TACTGCCCTC GGGGAGCTGA CTCTAAACTG GACTCATCAC CATGATCACA 1080
CCTGCCAACC CAGCAGAAAC ATTTAATCAA GACAGAAAGA GGTGAGCGAA AGTTAGAGAT 1140
AGTATTATGT TATTAACCAT ATCTGATTCA GTCTCAAAAA TCCTGAGAGG TTGATGTTAC 1200
TATATTCATT TTACAGATGG GGAAATGGAC GGTCCGAGAG GTTAAACAAA TTGCTCAAGG 1260
CTGCTCAGCC TGTGTGTGGC AAAGCCCAGG CCCAAACTCA GATCTCTGTG ACACTCCAGC 1320
GACACCTGAT GACATGGGCC GGGCGCTGAA TTGGGAAGGT GGGGAGTAAG GATGAAAAGA 1380
CCCAGTCTTC GTCGTAAGGC AGGTGGCCAA GACCCAGGCA AAGTTTCCAG ACGGCCGTCC 1440
CTGTGGCCAA CCTGGTCTCC TTCCTGACTG CGCCGCTGTA AACGTTGCTA GGGGACAGCG 1500
AACTGGGAAG GGGCAAAGGG TTTCCACCAG CTGGGGGCGG AGTCGGCCCT TTGTGGGTTC 1560
CCTCCGCCCA GGCTGACTAG TCCGGCGTTC TCCATTCCCG CGGCAGCACC CCCCCCACCC 1620
GGGGGAATCC TGGAGGGGCT ACAGGCGCGG GTGGTGGGGT GGCAGTCGCT GGCTGCGCCA 1680
GGATGGGGCG GCCCTCAGGG CAGTGCGGAG CCCACGTGCC GGGGAGCACC GGCCATGCCC 1740
GGCCCAGCCA GGCGTCGGCG CCCTCGGGCT TCTTCCCCCA GAGGGCGCAG GAGCTGGCTC 1800
AGGAGCCATT CCAGGAGCCG CGGACACTGT GCGCACGACA GGGTCCCTGG ATCGCCCCCA 1860
TTCCCCAACA TCCCTACGCC CCTACCTCTG CTTGTCTCCG GCCGCACCCG CCACCTCTGC 1920
ACCTCCGCAG TCACCACCAC GGAACTCCAG CACCCACCTC CTCGCCCCCC GCGGCGCGCC 1980
GGTCCCCGCA CCCCACGGCC CTCCCTGAGC CTCTCGCCCT 2020
|
